Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 834

DECLARATION re #832 MOTION in Limine No. 5: Exclude Expert Testimony Regarding Amgen's Replication of Roche's Cell Culture Media, #833 Memorandum in Support of Motion by Amgen Inc.. (Attachments: #1 Errata 1#2 Exhibit 2)(Gottfried, Michael)

Amgen Inc. v.sF. ge Me sa Hoffmann-LaRoche LTD et al

Case 1:05-cv-12237-WGY

Document 834-2

Filed 08/17/2007

Page 1Doc5 834 Att. 1 of . Page 1 of 5

Kevin Flowers
From: Sent: To: Kevin Flowers Friday, May 04, 2007 10:29 AM '[e-mail]'

Subject: RE: Letter to Kevin Flowers Pat, Just wanted to find out if the Roche medium had been shipped, or when you expect it will be shipped. Regards, Kevin -----Original Message----From: [e-mail] [mailto:[e-mail]] Sent: Wednesday, April 25, 2007 1:53 PM To: Kevin Flowers Cc: [e-mail]; [e-mail] Subject: RE: Letter to Kevin Flowers

Kevin,

I have been informed by Roche scientists in Penzberg that at the moment there is no cultivation media for fermentation available because they are in the midst of the manufacturing harvesting procedure this week, which does not require fresh cultivation media. Production of new media will begin next week and the earliest that the freshly prepared media can be shipped is Wednesday, May 2nd. I will alert you when it is shipped. Pat
Pat Carson Kaye Scholer LLP 425 Park Ave. New York, NY 10022 212-836-7466

7/25/2007

Dockets.Justia.com

Message Case 1:05-cv-12237-WGY

Document 834-2

Filed 08/17/2007

Page 2 of 5 Page 2 of 5

"Kevin Flowers" [e-mail] 04/24/2007 07:27 PM To [e-mail] cc: Subject: RE: Letter to Kevin Flowers Pat, Please have them send the "culture" medium (does that already contain methotrexate?) to: Richard D. Kolodner, Ph.D. Attn: James Mueller Laboratory of Cancer Genetics Ludwig Institute for Cancer Research UC San Diego School of Medicine CMM-East Room 3080 9500 Gilman Dr. La Jolla, CA 92093-0660 Regards, Kevin -----Original Message----From: [e-mail] [mailto:[e-mail]] Sent: Tuesday, April 24, 2007 10:14 AM To: Kevin Flowers Cc: [e-mail]; [e-mail] Subject: RE: Letter to Kevin Flowers

Kevin, One additional question. Roche has two types of media, preculture (without selection pressure) & culture (with selection pressure). Which one does Kolodner need? Thanks, Pat Pat Carson Kaye Scholer LLP 425 Park Ave. New York, NY 10022 212-836-7466

7/25/2007

Message Case 1:05-cv-12237-WGY

Document 834-2

Filed 08/17/2007

Page 3 of 5 Page 3 of 5

Patricia Carson/NY/US/KSFHH 04/24/2007 10:34 AM To "Kevin Flowers" [e-mail] [e-mail] cc: Subject: RE: Letter to Kevin Flowers Kevin, There was some confusion regarding the proper address for Dr. Kolodner last time. Please confirm the proper address by e-mail. We are hoping to get the shipment out today or tomorrow at the latest. thanks, Pat Pat Carson Kaye Scholer LLP 425 Park Ave. New York, NY 10022 212-836-7466

"Kevin Flowers" [e-mail] 04/19/2007 8:54 PM To <"Patricia Carson" [e-mail] <[e-mail] cc: Subject: RE: Letter to Kevin Flowers Pat, Thank you for your letter today. Please have your Roche contact send the media to Dr. Kolodner using the same address to which Roche sent the cells. Regards, Kevin

7/25/2007

Message Case 1:05-cv-12237-WGY

Document 834-2

Filed 08/17/2007

Page 4 of 5 Page 4 of 5

-----Original Message----From: [e-mail] [mailto:[e-mail]] Sent: Thursday, April 19, 2007 9:54 AM To: Kevin Flowers; [e-mail]; [e-mail]; Mark Izraelewicz; [e-mail]; [e-mail]; [e-mail] Subject: Letter to Kevin Flowers

on behalf of Pat Carson Yvette Negron Kaye Scholer LLP 425 Park Avenue New York, NY 10022 Tel. [phone] Fax. [phone] (See attached file: 78205A00.PDF)
The material in this transmission contains confidential information intended only for the addressee. If you are not the addressee, any disclosure or use of this information by you is strictly prohibited. If you have received this transmission in error, please delete it, destroy all copies, and notify Marshall, Gerstein & Borun by telephone [phone]. Thank you **********************************************************************

* * *

*

IRS CIRCULAR 230 DISCLOSURE: To ensure compliance with Treasury Department regulations, we inform you that any U.S. federal tax advice contained in this correspondence (including any attachments) is not intended or written to be used, and cannot be used for the purpose of (i) avoiding penalties

7/25/2007

Message Case 1:05-cv-12237-WGY

Document 834-2

Filed 08/17/2007

Page 5 of 5 Page 5 of 5

that may be imposed under the U.S. Internal Revenue Code or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein.
* IRS CIRCULAR 230 DISCLOSURE: * * *

To ensure compliance with Treasury Department reg

7/25/2007